Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005-03-20
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
ABSTRACT
PURPOSE
The optimal integration of chemotherapy with radiation (RT) for patients with early-stage breast cancer remains uncertain. We present the long-term results of a prospective randomized trial to address this question.
PATIENTS AND METHODS
Two hundred forty-four patients were randomly assigned after conservative breast surgery to receive 12 weeks of cyclophosphamide, doxorubicin, methotrexate, fluorouracil, and prednisone (CAMFP) before RT (CT-first) or after RT (RT-first). Median follow-up for surviving patients was 135 months.
RESULTS
There were no significant differences between the CT-first and RT-first arms in time to any event, distant metastasis, or death. Sites of first failure were also not significantly different.
CONCLUSION
Among breast cancer patients treated with conservative surgery, there is no advantage to giving RT before adjuvant chemotherapy. However, this study does not have enough statistical power to rule out a clinically important survival benefit for either sequence.
Related Questions
Results for oncotype Dx are not always available readily.
New comment by Radiation Oncologist at Spectrum Medical Group ( October 26, 2018)
I agree this should be the case, particularly in facilities where initial consultation by medical oncology and then waiting for the oncotype DX to come back can take extensiv...
Historically, chemotherapy has been delivered prior to radiation for breast cancer patients requiring it.
With the acceptance of shorter cour...
New comment by Radiation Oncologist at Beth Israel Deaconess Medical Center ( May 15, 2023)
Only 29% of patients in the WBI and APBI arms of the NSABP B-39 trial received chemotherapy (Vicini et al., PMID 31813636). Hence, the toxicity report was dominated by the res...
Assuming the patient had no prior radiation and has no evidence of metastatic disease, would you start with adjuvant radiotherapy or adjuvant systemic...
New answer by Radiation Oncologist at Beth Israel Deaconess Medical Center (August 17, 2023)
Endocrine therapy can be given simultaneously with RT without increasing toxicity or decreasing effectiveness, as shown in a randomized French-Swiss trial (Azria et al., PMID ...
Patient with pT2 N2a (6/9 LN+, 5 with macromets, 1 with focal ENE) ER/PR+, Her2- s/p mastectomy.
Is there compelling reason to start PMRT prior...
New comment by Radiation Oncologist at Northwestern University Feinberg School of Medicine ( October 13, 2024)
As always, I learn something new reading your answers. Thank you.